Determinants of plasma HDL concentrations and reverse cholesterol transport

被引:63
作者
Lewis, GF
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
high density lipoprotein; insulin resistance; lipase; lipoprotein; reverse cholesterol transport;
D O I
10.1097/01.hco.0000231405.76930.a0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review One or the major mechanisms whereby HDL particles are felt to protect against atherosclerosis is that of reverse cholesterol transport from atherosclerotic lesion macrophages to the liver, with subsequent excretion of cholesterol in the bile. This review focuses on recent progress in our understanding of reverse cholesterol transport and the factors that determine plasma HDL cholesterol concentrations. Recent findings The liver and intestine are the major sites of apolipoprotein A-I synthesis and nascent HDL particle secretion. The liver has recently been shown to be a major contributor to the plasma HDL-cholesterol concentration, but the precise site or mechanism whereby hepatically-synthesized HDL acquire the bulk of their lipid content remains to be determined. Contrastingly, macrophages contribute little to the plasma HDL cholesterol pool, whereas the quantatively small macrophage-specific reverse cholesterol transport contributes disproportionately to protection against atherosclerosis. Studies have highlighted the coordinate action of cell surface lipid transporters, cholesterol esterification enzymes and lipid transfer factors in the early steps of reverse cholesterol transport and the recycling of pre-beta HDL particles to create a ready supply of cholesterol acceptor HDL particles. Most of the variation in plasma HDL-cholesterol levels in human populations is accounted for by variations in HDL clearance rather than production. Summary Our understanding of the in-vivo metabolism of HDL particles and their role in reverse cholesterol transport is rapidly evolving, with long-standing concepts being constantly challenged by emerging evidence. An in-depth understanding of HDL metabolism will guide the rational design of novel pharmacological therapies that effectively protect against atherosclerosis.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 73 条
[21]   Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins [J].
Hammad, SM ;
Barth, JL ;
Knaak, C ;
Argraves, WS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12003-12008
[22]   Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis [J].
Hammad, SM ;
Stefansson, S ;
Twal, WO ;
Drake, CJ ;
Fleming, P ;
Remaley, A ;
Brewer, HB ;
Argraves, WS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10158-10163
[23]   INCREASED PLASMA AND RENAL CLEARANCE OF AN EXCHANGEABLE POOL OF APOLIPOPROTEIN A-I IN SUBJECTS WITH LOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL [J].
HOROWITZ, BS ;
GOLDBERG, IJ ;
MERAB, J ;
VANNI, TM ;
RAMAKRISHNAN, R ;
GINSBERG, HN .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1743-1752
[24]   The impact of phospholipid transfer protein (PLTP) on HDL metabolism [J].
Huuskonen, J ;
Olkkonen, VM ;
Jauhiainen, M ;
Ehnholm, C .
ATHEROSCLEROSIS, 2001, 155 (02) :269-281
[25]  
Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]
[26]  
JI J, 2005, J CLIN ENDOCRIN META
[27]   Inhibition of endothelial lipase causes increases HDL cholesterol levels in vivo [J].
Jin, WJ ;
Millar, JS ;
Broedl, U ;
Glick, JM ;
Rader, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :357-362
[28]   Lipases and HDL metabolism [J].
Jin, WJ ;
Marchadier, D ;
Rader, DJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (04) :174-178
[29]  
Jolley CD, 1998, J LIPID RES, V39, P2143
[30]   Lecithin cholesterol acyltransferase [J].
Jonas, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3) :245-256